Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2016 1
2017 4
2018 1
2019 1
2020 2
2021 5
2022 10
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
ENYGO-IJGC scientific writing and publication course: 2021 meeting summary.
Strojna AN, Kacperczyk-Bartnik J, Angeles MA, Bizzarri N, van Ramshorst GH, Theofanakis C, Bilir E, Razumova Z, Nikolova T, Selcuk I, Wan YL, Zalewski K, Lanner M, Pletnev A, Pareja R, Fotopoulou C, Kehoe S, Bąk J, Ramirez PT. Strojna AN, et al. Among authors: theofanakis c. Int J Gynecol Cancer. 2022 Dec 5;32(12):1599-1605. doi: 10.1136/ijgc-2022-003868. Int J Gynecol Cancer. 2022. PMID: 36418053 Review. No abstract available.
Best original research presented at the 24th European Congress on Gynaecological Oncology-Best of ESGO 2023.
Kacperczyk-Bartnik J, Bizzarri N, Zwimpfer TA, El Hajj H, Angeles MA, Tóth R, Theofanakis C, Bilir E, Gasimli K, Strojna AN, Nikolova T, Ayhan A, Lorusso D, Chiva L. Kacperczyk-Bartnik J, et al. Among authors: theofanakis c. Int J Gynecol Cancer. 2024 Apr 1;34(4):610-618. doi: 10.1136/ijgc-2023-005132. Int J Gynecol Cancer. 2024. PMID: 38088184 Review.
Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation.
Angeles MA, De Vitis LA, Cucinella G, Bonaldo G, Bizzarri N, Agusti N, Kacperczyk-Bartnik J, El Hajj H, Theofanakis C, Bilir E, Hsu HC, Estrada EE, Pareja R, Fotopoulou C, du Bois A, Plante M, Rauh-Hain JA, Mirza MR, Monk BJ, Gultekin M, Joura E, Fagotti A, Ramirez PT. Angeles MA, et al. Among authors: theofanakis c. Int J Gynecol Cancer. 2023 Dec 18:ijgc-2023-005109. doi: 10.1136/ijgc-2023-005109. Online ahead of print. Int J Gynecol Cancer. 2023. PMID: 38114163 Review. No abstract available.
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.
Andrikopoulou A, Theofanakis C, Markellos C, Kaparelou M, Koutsoukos K, Apostolidou K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F, Liontos M. Andrikopoulou A, et al. Among authors: theofanakis c. Cancers (Basel). 2023 Jul 6;15(13):3519. doi: 10.3390/cancers15133519. Cancers (Basel). 2023. PMID: 37444629 Free PMC article.
Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
Angeles MA, Bizzarri N, Shushkevich A, Gómez-Hidalgo NR, Theofanakis C, Strojna A, Kacperczyk-Bartnik J, Bilir E, Razumova Z, du Bois A, Cibula D, Concin N, Fotopoulou C, Rodolakis A, Harter P, Ramirez PT. Angeles MA, et al. Among authors: theofanakis c. Int J Gynecol Cancer. 2022 Apr 4;32(4):468-473. doi: 10.1136/ijgc-2022-003397. Int J Gynecol Cancer. 2022. PMID: 35320115 No abstract available.
32 results